newsfilter
← Latest News
FDA Approved Drugs·

Approval of Atebrioz, Nda #221198 (Type 1 - New Molecular Entity)

Approval Date: 09/25/2026; Drug Name: Atebrioz, Nda #221198; Active Ingredients: ZILURGISERTIB; Company: Incyte Corp; Submission Status: Approval; Submission Classification: Type 1 - New Molecular Entity; Application Number: 221198

Company
INCYTE CORP
Keywords
INCYTE CORP